Features Archives - Page 16 of 20

Features

BaseLaunch Accelerator gains another healthcare partner

BaseLaunch Accelerator gains another healthcare partner Pharma and diagnostics company Roche has joined Johnson & Johnson Innovation, Novartis Venture Fund and Pfizer to become the…

clement08.09.2017

Features

Michael N. Hall receives Lasker Award

clement07.09.2017

Features

Novartis crosses FDA finish line with monumental CAR-T leukemia approval

clement31.08.2017

Features

Aurealis Pharma AG raises 5.6 million Swiss francs

Aurealis Pharma AG has closed a 5.6 million Swiss franc financing round. Headquartered in Basel and Finland, the biotechnology company develops medications for cancer and…

clement28.08.2017

Features

Homology Med bags $83.5M more, fueling push for gene editing twist

clement15.08.2017

Features

Cellestia compound enters into clinical development

The Basel-based biotechnology company Cellestia has received approval for the first clinical trial on its compound CB-103. The clinical trial will be open to patients…

clement15.08.2017

Features

Roivant Sciences secures USD one billion investment

clement10.08.2017

Features

Roche develops diabetes data platform

The Basel-based pharmaceutical company Roche has entered a cooperation agreement with the consultancy firm Accenture. The aim is to develop a data platform that connects…

clement09.08.2017

Features

Only two years after founding, IFM therapeutics gets sold for up to $2.3B to BMS

clement04.08.2017

Features

U.K. Proposes Post-Brexit Fund to Close Technology Gap With U.S.

clement03.08.2017

Features

BaseLaunch Accelerator gains another healthcare partner

Michael N. Hall receives Lasker Award

Novartis crosses FDA finish line with monumental CAR-T leukemia approval

Aurealis Pharma AG raises 5.6 million Swiss francs

Homology Med bags $83.5M more, fueling push for gene editing twist

Cellestia compound enters into clinical development

Roivant Sciences secures USD one billion investment

Roche develops diabetes data platform

Only two years after founding, IFM therapeutics gets sold for up to $2.3B to BMS

U.K. Proposes Post-Brexit Fund to Close Technology Gap With U.S.

Useful links

Contact us

Sign up for our newsletter and event invitations

Follow us